Modulation of P2 Receptors on Pancreatic &bgr;-cells by Agonists and Antagonists: A Molecular Target for Type 2 Diabetes Treatment

Publisher： Bentham Science Publishers

E-ISSN： 1875-6417|9|3|228-236

ISSN： 1573-3998

Source： Current Diabetes Reviews, Vol.9, Iss.3, 2013-05, pp. : 228-236

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pancreatic #946;-Cells and Type 2 Diabetes Development

By  

Current Diabetes Reviews, Vol. 13, Iss. 2, 2017-02 ,pp. : 108-121

Bentham Science Publishers

Access to resources Recommend Favorite

GLP-1 receptor agonists in the treatment of Type 2 diabetes

By Ahrén Bo  

Diabetes Management, Vol. 3, Iss. 5, 2013-09 ,pp. : 401-413

Future Medicine

Access to resources Recommend Favorite

Modulation of Monoaminergic Neural Circuits: Potential for the Treatment of Type 2 Diabetes Mellitus

By Pijl H.   Meinders E.A.  

Treatments in Endocrinology, Vol. 1, Iss. 2, 2002-02 ,pp. : 71-78

Adis International

Access to resources Recommend Favorite

Dual Peroxisome Proliferator-Activated Receptor-α/ Agonists: In the Treatment of Type 2 Diabetes Mellitus and the Metabolic Syndrome

By Pershadsingh Harrihar A.  

Treatments in Endocrinology, Vol. 5, Iss. 2, 2006-01 ,pp. : 89-99

Adis International

Access to resources Recommend Favorite

New Player on An Old Field; the Keap1/Nrf2 Pathway as a Target for Treatment of Type 2 Diabetes and Metabolic Syndrome

By  

Current Diabetes Reviews, Vol. 9, Iss. 2, 2013-03 ,pp. : 137-145

Bentham Science Publishers

Access to resources Recommend Favorite